Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Roberto Salvatori is an Endocrinologist in Baltimore, Maryland. Dr. Salvatori has been practicing medicine for over 38 years and is rated as an Elite doctor by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. He is also highly rated in 41 other conditions, according to our data. His top areas of expertise are Growth Hormone Deficiency (GHD), Hypopituitarism, Pituitary Tumor, Cushing's syndrome, and Hormone Replacement Therapy (HRT). Dr. Salvatori is currently accepting new patients.
Jason Sheehan is a Neurosurgery doctor in Charlottesville, Virginia. Dr. Sheehan has been practicing medicine for over 25 years and is rated as a Distinguished doctor by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. He is also highly rated in 56 other conditions, according to our data. His top areas of expertise are Cerebral Arteriovenous Malformation, Arteriovenous Malformation, Meningioma, Gamma Knife Radiosurgery, and Rhizotomy. Dr. Sheehan is currently accepting new patients.
Mary Vance is an Endocrinologist in Charlottesville, Virginia. Dr. Vance has been practicing medicine for over 46 years and is rated as a Distinguished doctor by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. She is also highly rated in 43 other conditions, according to our data. Her top areas of expertise are Pituitary Tumor, Acromegaly, Hypothalamic Tumor, Hypopituitarism, and Gamma Knife Radiosurgery. Dr. Vance is currently accepting new patients.
Summary: This is an open-label, single treatment arm, multicenter study to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of Debio 4126 in the treatment of participants with Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine tumors (GEP-NETs).